메뉴 건너뛰기




Volumn 16, Issue 5, 1999, Pages 772-776

Analyzing rich data using different methods provided by NONMEN: Pharmacokinetics of telmisartan following intravenous infusion to healthy volunteers

Author keywords

Bioavailability; Nonlinear mixed effects modeling (NONMEM); Pharmacokinetics; Telmisartan

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; TELMISARTAN;

EID: 0032934909     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011997229669     Document Type: Article
Times cited : (3)

References (5)
  • 2
    • 0345728696 scopus 로고    scopus 로고
    • Unpublished data. Dep. of Pharmacokinetics and Metabolism. Boehringer Ingelheim Pharma KG, Biberach
    • 2. Unpublished data. Dep. of Pharmacokinetics and Metabolism. Boehringer Ingelheim Pharma KG, Biberach.
  • 3
    • 0003747347 scopus 로고
    • San Francisco: NONMEM Project Group, University of California at San Francisco
    • 3. S. L. Beal and L. B. Sheiner, eds. NONMEM user's guides. San Francisco: NONMEM Project Group, University of California at San Francisco, 1992.
    • (1992) NONMEM User's Guides
    • Beal, S.L.1    Sheiner, L.B.2
  • 4
  • 5
    • 0023280963 scopus 로고
    • Population pharmacokinetics of alfentanil: The average dose-serum concentration relationship and inter-individual variability in patients
    • 5. P. O. Maitre, S. Vozeh, J. Heykants, D. A. Thomson, and D. R. Stanski. Population pharmacokinetics of alfentanil: the average dose-serum concentration relationship and inter-individual variability in patients. Anesthesiology 66:3-12, 1987.
    • (1987) Anesthesiology , vol.66 , pp. 3-12
    • Maitre, P.O.1    Vozeh, S.2    Heykants, J.3    Thomson, D.A.4    Stanski, D.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.